Feasibility of Assessing Patient Health Benefits and Incurred Costs Resulting from Early Dysphagia Intervention during and Immediately after Chemoradiotherapy for Head-and-Neck Cancer
Abstract
Share and Cite
Martino, R.; Ringash, J.; Durkin, L.; Greco, E.; Huang, S.H.; Xu, W.; Longo, C.J. Feasibility of Assessing Patient Health Benefits and Incurred Costs Resulting from Early Dysphagia Intervention during and Immediately after Chemoradiotherapy for Head-and-Neck Cancer. Curr. Oncol. 2017, 24, 466-476. https://doi.org/10.3747/co.24.3543
Martino R, Ringash J, Durkin L, Greco E, Huang SH, Xu W, Longo CJ. Feasibility of Assessing Patient Health Benefits and Incurred Costs Resulting from Early Dysphagia Intervention during and Immediately after Chemoradiotherapy for Head-and-Neck Cancer. Current Oncology. 2017; 24(6):466-476. https://doi.org/10.3747/co.24.3543
Chicago/Turabian StyleMartino, R., J. Ringash, L. Durkin, E. Greco, S. Hui Huang, W. Xu, and C. J. Longo. 2017. "Feasibility of Assessing Patient Health Benefits and Incurred Costs Resulting from Early Dysphagia Intervention during and Immediately after Chemoradiotherapy for Head-and-Neck Cancer" Current Oncology 24, no. 6: 466-476. https://doi.org/10.3747/co.24.3543
APA StyleMartino, R., Ringash, J., Durkin, L., Greco, E., Huang, S. H., Xu, W., & Longo, C. J. (2017). Feasibility of Assessing Patient Health Benefits and Incurred Costs Resulting from Early Dysphagia Intervention during and Immediately after Chemoradiotherapy for Head-and-Neck Cancer. Current Oncology, 24(6), 466-476. https://doi.org/10.3747/co.24.3543